The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.

To compare safety, efficacy and cost–effectiveness of voriconazole with natamycin, a double-blinded RCT was conducted in two hospitals in India in 2010. The design was superior to antecedent ...

We all want to keep our eyes healthy and our vision crisp. Some of your daily habits might be secretly sabotaging your ...

Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced a $3 million seed financing round for VisiRose, Inc.

Dealing with red, itchy eyelids? The culprit could be a common mite. This article is sponsored by XDEMVY. Dr. Watson is a ...

They report a case of endophthalmitis and undertook a literature review to identify previous infections with this pathogen.

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...

Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.

VisiRose Inc. ('VisiRose' or the 'Company'), a privately-held, clinical-stage biotechnology company developing novel ocular ...

Biopharmaceuticals announced a $3M seed financing round for VisiRose, Provectus’s Founded Entity that is developing novel ...

DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.